(4R)-4-[(2S)-4,4-difluoro-2-phenylpiperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide

C122H138F6N20O19S10 — CID 157240341

IUPAC(4R)-4-[(2S)-4,4-difluoro-2-phenylpiperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide
SMILESCC(C)(O)[C@@H]1CCN([C@@H]2CCOc3cc(S(=O)(=O)Nc4ncns4)ccc32)[C@H](c2ccc(F)cc2)C1.CC(C)(O)[C@@H]1CCN([C@H]2CCOc3cc(S(=O)(=O)Nc4ncns4)ccc32)[C@H](c2ccc(F)cc2)C1.CC(C)(O)[C@H]1CCN([C@@H]2CCOc3cc(S(=O)(=O)Nc4ncns4)ccc32)[C@@H](c2ccc(F)cc2)C1.CC(C)(O)[C@H]1CCN([C@H]2CCOc3cc(S(=O)(=O)Nc4ncns4)ccc32)[C@@H](c2ccc(F)cc2)C1.O=S(=O)(Nc1ncns1)c1ccc2c(c1)OCC[C@H]2N1CCC(F)(F)C[C@H]1c1ccccc1
InChIInChI=1S/4C25H29FN4O4S2.C22H22F2N4O3S2/c4*1-25(2,31)17-9-11-30(22(13-17)16-3-5-18(26)6-4-16)21-10-12-34-23-14-19(7-8-20(21)23)36(32,33)29-24-27-15-28-35-24;23-22(24)9-10-28(19(13-22)15-4-2-1-3-5-15)18-8-11-31-20-12-16(6-7-17(18)20)33(29,30)27-21-25-14-26-32-21/h4*3-8,14-15,17,21-22,31H,9-13H2,1-2H3,(H,27,28,29);1-7,12,14,18-19H,8-11,13H2,(H,25,26,27)/t2*17-,21+,22+;2*17-,21-,22+;18-,19+/m10101/s1
InChIKeyAVDDNPUNWCVIJC-XXDWUKOBSA-N
MW2623.22 g/mol
LogP22.74
Rot. Bonds29

About (4R)-4-[(2S)-4,4-difluoro-2-phenylpiperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide

(4R)-4-[(2S)-4,4-difluoro-2-phenylpiperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide (PubChem CID 157240341) has the molecular formula C122H138F6N20O19S10 and a molecular weight of 2623.22 g/mol. Its IUPAC name is (4R)-4-[(2S)-4,4-difluoro-2-phenylpiperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide.

Molecular Properties

Compound Name(4R)-4-[(2S)-4,4-difluoro-2-phenylpiperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide
PubChem CID157240341
Molecular FormulaC122H138F6N20O19S10
Molecular Weight2623.22 g/mol
Exact Mass2620.76
IUPAC Name(4R)-4-[(2S)-4,4-difluoro-2-phenylpiperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide
SMILESCC(C)(O)[C@@H]1CCN([C@@H]2CCOc3cc(S(=O)(=O)Nc4ncns4)ccc32)[C@H](c2ccc(F)cc2)C1.CC(C)(O)[C@@H]1CCN([C@H]2CCOc3cc(S(=O)(=O)Nc4ncns4)ccc32)[C@H](c2ccc(F)cc2)C1.CC(C)(O)[C@H]1CCN([C@@H]2CCOc3cc(S(=O)(=O)Nc4ncns4)ccc32)[C@@H](c2ccc(F)cc2)C1.CC(C)(O)[C@H]1CCN([C@H]2CCOc3cc(S(=O)(=O)Nc4ncns4)ccc32)[C@@H](c2ccc(F)cc2)C1.O=S(=O)(Nc1ncns1)c1ccc2c(c1)OCC[C@H]2N1CCC(F)(F)C[C@H]1c1ccccc1
InChIInChI=1S/4C25H29FN4O4S2.C22H22F2N4O3S2/c4*1-25(2,31)17-9-11-30(22(13-17)16-3-5-18(26)6-4-16)21-10-12-34-23-14-19(7-8-20(21)23)36(32,33)29-24-27-15-28-35-24;23-22(24)9-10-28(19(13-22)15-4-2-1-3-5-15)18-8-11-31-20-12-16(6-7-17(18)20)33(29,30)27-21-25-14-26-32-21/h4*3-8,14-15,17,21-22,31H,9-13H2,1-2H3,(H,27,28,29);1-7,12,14,18-19H,8-11,13H2,(H,25,26,27)/t2*17-,21+,22+;2*17-,21-,22+;18-,19+/m10101/s1
InChIKeyAVDDNPUNWCVIJC-XXDWUKOBSA-N
XLogP22.74
TPSA503.02 Ų
H-Bond Donors9
H-Bond Acceptors39
Rotatable Bonds29
Heavy Atoms177
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002623.22
LogP ≤ 522.74
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1039

Analyze (4R)-4-[(2S)-4,4-difluoro-2-phenylpiperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (4R)-4-[(2S)-4,4-difluoro-2-phenylpiperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide?
The IUPAC name of (4R)-4-[(2S)-4,4-difluoro-2-phenylpiperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide (CID 157240341) is (4R)-4-[(2S)-4,4-difluoro-2-phenylpiperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide.
What is the SMILES notation for (4R)-4-[(2S)-4,4-difluoro-2-phenylpiperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide?
The canonical SMILES for (4R)-4-[(2S)-4,4-difluoro-2-phenylpiperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide is CC(C)(O)[C@@H]1CCN([C@@H]2CCOc3cc(S(=O)(=O)Nc4ncns4)ccc32)[C@H](c2ccc(F)cc2)C1.CC(C)(O)[C@@H]1CCN([C@H]2CCOc3cc(S(=O)(=O)Nc4ncns4)ccc32)[C@H](c2ccc(F)cc2)C1.CC(C)(O)[C@H]1CCN([C@@H]2CCOc3cc(S(=O)(=O)Nc4ncns4)ccc32)[C@@H](c2ccc(F)cc2)C1.CC(C)(O)[C@H]1CCN([C@H]2CCOc3cc(S(=O)(=O)Nc4ncns4)ccc32)[C@@H](c2ccc(F)cc2)C1.O=S(=O)(Nc1ncns1)c1ccc2c(c1)OCC[C@H]2N1CCC(F)(F)C[C@H]1c1ccccc1.
What is the InChIKey of (4R)-4-[(2S)-4,4-difluoro-2-phenylpiperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide?
The InChIKey is AVDDNPUNWCVIJC-XXDWUKOBSA-N. The full InChI is InChI=1S/4C25H29FN4O4S2.C22H22F2N4O3S2/c4*1-25(2,31)17-9-11-30(22(13-17)16-3-5-18(26)6-4-16)21-10-12-34-23-14-19(7-8-20(21)23)36(32,33)29-24-27-15-28-35-24;23-22(24)9-10-28(19(13-22)15-4-2-1-3-5-15)18-8-11-31-20-12-16(6-7-17(18)20)33(29,30)27-21-25-14-26-32-21/h4*3-8,14-15,17,21-22,31H,9-13H2,1-2H3,(H,27,28,29);1-7,12,14,18-19H,8-11,13H2,(H,25,26,27)/t2*17-,21+,22+;2*17-,21-,22+;18-,19+/m10101/s1.
What are the key properties of (4R)-4-[(2S)-4,4-difluoro-2-phenylpiperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide?
(4R)-4-[(2S)-4,4-difluoro-2-phenylpiperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide has a molecular weight of 2623.22 g/mol, XLogP of 22.74, 29 rotatable bonds, 9 hydrogen bond donors, and 39 hydrogen bond acceptors.
Where does this data come from?
All data for (4R)-4-[(2S)-4,4-difluoro-2-phenylpiperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4S)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2S,4R)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide;(4R)-4-[(2R,4S)-2-(4-fluorophenyl)-4-(2-hydroxypropan-2-yl)piperidin-1-yl]-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydro-2H-chromene-7-sulfonamide is sourced from PubChem (CID 157240341), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).